Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Northwestern University Identifier:
First received: May 2, 2000
Last updated: February 18, 2011
Last verified: February 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)